Eikon Therapeutics, Inc.: H.C. Wainwright initiates coverage with buy rating and $23 target price
EIKN•H.C. Wainwright initiated coverage of Eikon Therapeutics, Inc. with a buy rating and a $23 target price.
Related News
Texas Roadhouse: BofA Global Research cuts price objective to $225 from $276
TXRH•
Wells Fargo cuts Charles Schwab target price to $103 from $105
SCHW•
Alcoa: Wells Fargo cuts target price to $58 from $60
AA•
J.B. Hunt Transport Services cuts target price to $285 from $305
JBHT•
Marsh target price raised to $197 from $183 by Wells Fargo
MRSH•